[Experience of surgical resection of Bismuth-Corlette type I and II hilar cholangiocarcinoma].

Abstract

OBJECTIVE:

To report the experience of surgical resection of Bismuth-Corlette type I and II hilar cholangiocarcinoma.

METHODS:

From January 1998 and January 2008, 52 cases of Bismuth-Corlette type I and II hilar cholangiocarcinoma were operated on. The clinical data and long-term outcome of the patients was retrospectively analyzed.

RESULTS:

Of the 52 cases, 44 cases (84.6%) received operation, 28 patients underwent radical resection (63.6%) and 16 patients (36.4%) underwent palliative resection.Seven patients were resected on caudate lobe and other section and lobe of the liver; among them, 2 patients received combined portal vein resection and 4 underwent combined hepatic artery resection respectively. Eleven cases developed postoperative complications and another one died in hospital. The median survival was 33.2 months in radical resection group, and 1-, 3-, 5-year survival rate was 82.6%, 47.8%, 34.7%, respectively, which was significant greater than those in the palliative resection group (41.6%, 16.6%, 8.3%, respectively) (P < 0.05). The median survival was 16.7 months in the palliative resection group.

CONCLUSIONS:

The radical resection is still the best treatment for Bismuth-Corlette type I and II hilar cholangiocarcinoma. Intraoperative pathology for resection margin, and combined liver resection, portal vein resection and hepatic artery resection can help improve the radical resection rate.

• Authors: Hao-liang Zhao, Zhi-gang Wei, Jie-feng He, Jian-sheng Liu, Ying Zhao, Min-sheng Bao
• Journal: Zhonghua wai ke za zhi [Chinese journal of surgery] (Zhonghua Wai Ke Za Zhi) Vol. 47 Issue 15 Pg. 1145-7 (Aug 01 2009) ISSN: 0529-5815 [Print] China
• PMID: 20021904 (Publication Type: English Abstract, Journal Article)

Topics

• Aged
• Aged, 80 and over
• Bile Duct Neoplasms (surgery)
• Bile Ducts, Intrahepatic
• Cholangiocarcinoma (surgery)
• Female
• Follow-Up Studies
• Hepatectomy
• Hepatic Artery (surgery)
• Humans
• Male
• Middle Aged
• Portal Vein (surgery)
• Prognosis
• Retrospective Studies
• Survival Rate